A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

E Ellebaek; R B Holmstrom; C H Ruhlmann; H Schmidt; C A Haslund; M Donia; A von Heymann; C Johansen; L Bastholt; I M Svane

doi:10.1016/j.annonc.2021.08.1456

A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

E Ellebaek, R B Holmstrom, C H Ruhlmann, H Schmidt, C A Haslund, M Donia, A von Heymann, C Johansen, L Bastholt, I M Svane

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	1071P
Journal	Annals of Oncology
Volume	32
Issue number	Suppl. 5
Pages (from-to)	S889-S889
ISSN	0923-7534
DOIs	https://doi.org/10.1016/j.annonc.2021.08.1456
Publication status	Published - 2021
Event	ESMO Congress 2021 - Virtual conference Duration: 16 Sept 2021 → 21 Sept 2021 https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme

Conference

Conference	ESMO Congress 2021
Location	Virtual conference
Period	16/09/2021 → 21/09/2021
Internet address	https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme

Access to Document

10.1016/j.annonc.2021.08.1456

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Ellebaek, E., Holmstrom, R. B., Ruhlmann, C. H., Schmidt, H., Haslund, C. A., Donia, M., von Heymann, A., Johansen, C., Bastholt, L., & Svane, I. M. (2021). A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients. Annals of Oncology, 32(Suppl. 5), S889-S889. Article 1071P. https://doi.org/10.1016/j.annonc.2021.08.1456

@article{6e09f4f4e38641abb0bc2c02c776f886,

title = "A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients",

author = "E Ellebaek and Holmstrom, {R B} and Ruhlmann, {C H} and H Schmidt and Haslund, {C A} and M Donia and {von Heymann}, A and C Johansen and L Bastholt and Svane, {I M}",

year = "2021",

doi = "10.1016/j.annonc.2021.08.1456",

language = "English",

volume = "32",

pages = "S889--S889",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Suppl. 5",

note = "ESMO Congress 2021 ; Conference date: 16-09-2021 Through 21-09-2021",

url = "https://www.esmo.org/meetings/past-meetings/esmo-congress-2021/programme",

}

Ellebaek, E, Holmstrom, RB, Ruhlmann, CH, Schmidt, H, Haslund, CA, Donia, M, von Heymann, A, Johansen, C, Bastholt, L & Svane, IM 2021, 'A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients', Annals of Oncology, vol. 32, no. Suppl. 5, 1071P, pp. S889-S889. https://doi.org/10.1016/j.annonc.2021.08.1456

TY - ABST

T1 - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients

AU - Ellebaek, E

AU - Holmstrom, R B

AU - Ruhlmann, C H

AU - Schmidt, H

AU - Haslund, C A

AU - Donia, M

AU - von Heymann, A

AU - Johansen, C

AU - Bastholt, L

AU - Svane, I M

PY - 2021

Y1 - 2021

U2 - 10.1016/j.annonc.2021.08.1456

DO - 10.1016/j.annonc.2021.08.1456

M3 - Conference abstract in journal

SN - 0923-7534

VL - 32

SP - S889-S889

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 5

M1 - 1071P

T2 - ESMO Congress 2021

Y2 - 16 September 2021 through 21 September 2021

ER -